23rd Congress of the European Committee for the Treatment and Research in Multiple Sclerosis (ECTRIMS)
&
12th Annual Conference of Rehabilitation in MS (RIMS)

11.10.2007 - 14.10.2007
Please select a day:
11.10.2007
12.10.2007
13.10.2007
14.10.2007
Search
Personal programme
Please enter your email address here in order to bring up your personal programme



Home - 13.10.2007


Saturday, October 13, 2007
15:30 - 17:00

Poster topic 16

Genetics and transcriptomics

Epigenetic X-chromosome inactivation: a possible explanation for the female predisposition to multiple sclerosis
   P 640
N. Couturier, I. Rebeix, H. Merle, C. Fontenille-Gout, G. Edan, B. Fontaine, M. Clanet, D. Brassat (Toulouse, Paris, Rennes, F)
Progression in familial and non-familial multiple sclerosis
   P 641
M.W. Koch, M. Uyttenboogaart, M. Heerings, D.J. Heersema, J.P. Mostert, J. De Keyser (Groningen, NL)
Osteopontin gene variations protect against multiple sclerosis development and evolution
   P 642
C. Comi, L. Castelli, E. Cerutti, A. Chiocchetti, D. Galimberti, C. Fenoglio, G. Cappellano, S. Calzoni, P. Naldi, S. Bonissoni, M. Carecchio, N. Nasuelli, E. Scarpini, F. Monaco, U. Dianzani (Novara, Milan, I)
HLA-DRB1* in multiple sclerosis severity in Portuguese population
   P 643
E. Rio, B. Lima, S. Oliveira, C. Lima, M.J. Peixoto, H. Alves (Porto, P)
HLA and multiple sclerosis course in patients from the north of Portugal
   P 644
E. Rio, S. Oliveira, B. Lima, C. Lima, F. Mendes, H. Alves (Porto, P)
Genetic analysis of B-cell translocation gene 1 polymorphisms in multiple sclerosis
   P 645
M. Camiña-Tato, C. Tur, N. Téllez, J. Río, X. Montalban, M. Comabella (Barcelona, E)
Multiple sclerosis and polymorphisms in CD79b gene on chromosome 17q23
   P 646
T. Mihalova, J.A. Woolmore, M.J. Stone, S. Eyre, A. Barton, P. Hoban, J. Worthington, R. Strange, C.P. Hawkins (Stoke-on-Trent, Manchester, UK)
New evidence for the involvement of the APOE e2 allele in multiple sclerosis susceptibility
   P 647
A. Bettencourt, A. Martins da Silva, C. Pereira, D. Mendonça, E. Vilhena, E. Santos, E. Coutinho, P. Costa, S. Cavaco, L. Monteiro, B. Martins da Silva (Porto, Barcelos, P)
APOE genotypes in a Portuguese multiple sclerosis population: no association with demographic and clinical variables
   P 648
A. Martins da Silva, E. Vilhena, A. Bettencourt, C. Pereira, E. Santos, E. Coutinho, L. Monteiro, S. Cavaco, P. Costa, D. Mendonça, B. Martins da Silva (Porto, Barcelos, P)
Paraoxonase 2 gene C311S polymorphism and the risk of multiple sclerosis
   P 649
M. Nojszewska, A. Slowik, T. Rog, B. Zakrzewska-Pniewska, J. Pniewski, M. Dorobek, M. Styczynska on behalf of the Polish MS Genetics Study Group
PVRL2 and APOE polymorphisms and severity of multiple sclerosis
   P 650
M. Matiello, B. Weinshenker, D. Hebrink, E. Atkinson, O. Kantarci (Rochester, USA)
Genetic analysis of AQP4 in neuromyelitis optica patients
   P 651
M. Matiello, D. Hebrink, A. Jacob, J. Schaefer-Klein, B. Weinshenker for the NMO Genetics Consortium
Peripheral mRNA expression of brain-derived neurotrophic factor Val66Met polymorphism in patients with relapsing-remitting multiple sclerosis
   P 652
M. Liguori, F. Fera, A. Patitucci, I. Manna, P. Valentino, F. Condino, A. Cerasa, M. Gioia, R. Cittadella, A. Quattrone (Mangone, Catanzaro, I)
Relapsing-remitting multiple sclerosis and protective effect of a NOS2A gene variant
   P 653
I. Manna, M. Liguori, P. Valentino, F. Condino, A. Carpino, A. La Russa, A. Clodomiro, R. Nisticò, G. Di Palma, A. Quattrone (Cosenza, Catanzaro, I)
No association between estrogen receptor 1 gene polymorphisms and susceptibility to multiple sclerosis
   P 654
I. Manna, P. Valentino, F. Condino, M. Liguori, A. La Russa, A. Clodomiro, R. Nisticò, G. Di Palma, V. Andreoli, R. Cittadella, A. Quattrone (Cosenza, Catanzaro, I)
Mutational screening of the eIF2B5 gene in sib pairs affected by multiple sclerosis
   P 655
R.L. Mazzei, M. Liguori, F. Conforti, C. Ungaro, M. Muglia, T. Sprovieri, A. Patitucci, A. Magariello, A. Gabriele, L. Citrigno, L. Crescibene, A. Quattrone (Mangone, I)
The IFIH1 region, previously associated with T1D, confers susceptibility to multiple sclerosis in the Spanish population
   P 656
A. Martínez, M. Cénit, A. Mas-Fontao, V. De las Heras, R. Alvarez-Lafuente, R. Arroyo, E. Urcelay (Madrid, E)
The NOS2A gene plays a role in susceptibility to multiple sclerosis in the Spanish population
   P 657
A. Mas-Fontao, E. Urcelay, V. De las Heras, R. Arroyo, A. Martínez (Madrid, E)
Multiple sclerosis association with the MAPT (microtubule associated protein, tau) chromosomal region in the Spanish population
   P 658
A. Mas-Fontao, M. Bartolomé, V. De las Heras, R. Arroyo, E. De la Concha, A. Martínez, E. Urcelay (Madrid, E)
Genetic analysis of CD46, the HHV-6 cell receptor, in Spanish multiple sclerosis patients and controls
   P 659
R. Alvarez-Lafuente, F. Blanco-Kelly, A. Martinez, A. Mas-Fontao, V. De las Heras, M. Garcia-Montojo, E. De la Concha, M. Bartolomé, E. Urcelay, R. Arroyo (Madrid, E)
MHC2TA +1614 genotype: MS patients with the minor allele C and HHV-6a active infection. A clinical study
   P 660
V. De las Heras, R. Alvarez-Lafuente, A. Mas-Fontao, A. Martinez, M. Garcia-Montojo, E. Urcelay, M. Bartolomé, E. De la Concha, R. Arroyo (Madrid, E)
HLA genetics of multiple sclerosis in the Israeli Arab populations
   P 661
G. Benedek, T. Paperna, S. Israel, I. Lejbkowicz, C. Brautbar, J. Oksenberg, A. Miller (Jerusalem, Haifa, IL; San Francisco, USA)
Influence of gene polymorphisms on MS susceptibility and clinical presentation in childhood multiple sclerosis patients
   P 662
W. Stark, D. van Rossum, A. Rosenberger, H. Bickeböller, W. Brück, J. Gärtner (Gottingen, D)
Influence of histocompatibility genes on the clinical course of patients with relapsing-remitting multiple sclerosis treated with interferon beta-1a
   P 663
S. Flechter, T. Klein, L. Pollak (Tel Aviv, IL)
Predisposing and protective effects of the HLA complex in Australians with multiple sclerosis
   P 664
T.J. Kilpatrick, J. Stankovich, M. Bahlo, B. Tait, G. Stewart, S. Foote, J. Rubio (Melbourne, Sydney, Tasmania, AUS)
APOC1 and APOA1 polymorphisms and cognitive impairment in patients with multiple sclerosis
   P 665
G. Koutsis, E. Giogkaraki, G. Karadima, C. Sfagos, C. Potagas, D. Vassilopoulos, M. Panas (Athens, GR)
The effect of APOA1 and APOC3 polymorphisms on the disease course and severity of multiple sclerosis
   P 666
G. Koutsis, G. Karadima, D. Mandellos, G. Karachalios, C. Sfagos, D. Vassilopoulos, M. Panas (Athens, GR)
Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to multiple sclerosis
   P 667
C. Fenoglio, D. Galimberti, D. Scalabrini, M. De Riz, C. Comi, E. Venturelli, F. Cortini, M. Piola, N. Bresolin, E. Scarpini, U. Dianzani, S. D'Alfonso, M. Leone, F. Monaco (Milan, Novara, I)
3’UTR C2370A allele of the IL-23 receptor gene is associated with relapsing-remitting multiple sclerosis
   P 668
Z. Illes, B. Farago, A. Peterfalvi, L. Magyari, E. Pozsonyi, C. Rozsa, S. Komoly, B. Melegh (Pecs, Budapest, HUN)
Oligoclonal IgG bands and IgG index of Iranian multiple sclerosis patients with different CD24 gene alleles
   P 669
M. Saadatnia, A. Valian, M.R. Najafi, M. Etemadifar, A. Ronaghi, A.H. Maghzi, F. Najafi (Isfahan, IR)
Clinical expression of multiple sclerosis and the polymorphisms of the Chitotriosidase
   P 670
M.L. Fois, A. Angius, G. Arru, A. Sanna, R. Stradoni, G. Rosati, S. Musumeci, S. Sotgiu (Sassari, Alghero, Pula, I)
Preservation of grey matter volume in multiple sclerosis patients with the met allele of the rs6265 (Val66Met) SNP of brain-derived neurotrophic factor
   P 671
R. Zivadinov, B. Weinstock-Guttman, R.H.B. Benedict, M. Tamaño-Blanco, S. Hussein, N. Abdelrahman, J. Durfee, M. Ramanathan (Buffalo, USA)
The impact of HLA-A and –DRB1 on age at onset, disease course and severity in Scandinavian multiple sclerosis patients
   P 672
C. Smestad, B. Brynedal, G. Jonasdottir, Å.R. Lorentzen, T. Masterman, E. Åkesson, A. Spurkland, B.A. Lie, J. Palmgren, E.G. Celius, J. Hillert, H.F. Harbo (Oslo, N; Stockholm, S)
Matrix metalloproteinase-9 gene polymorphisms in multiple sclerosis
   P 673
Y. Benešová, M. Beránek, P. Štourac, M. Hladíková, Z. Kadanka, A. Vašku (Brno, CZ)
HLA DPB1*0501 allele is not associated with neuromyelitis optica
   P 674
A. Jacob, A. Barker, D. Payne, K. Poulton, M. Boggild (Liverpool, Manchester, UK)
Transmission of class I / II multi-locus MHC haplotypes and multiple sclerosis susceptibility: accounting for linkage disequilibrium
   P 675
M.J. Chao, G-Z. Lui, M.C.N.M. Barnardo, M.R. Lincoln, S.V. Ramagopalan, B.M. Herrera, D.A. Dyment, A.D. Sadovnick, G.C. Ebers (Oxford, UK; Vancouver, CAN)
The role of MHC2TA polymorphisms and susceptibility to disease in Northern Irish multiple sclerosis patients
   P 676
C. O'Doherty, S. Hawkins, M. Rooney, K. Vandenbroeck (Belfast, UK)
Polymorphisms in ITGA4 and susceptibility to multiple sclerosis: a study in Spanish-Basque and Nordic populations
   P 677
C. O'Doherty, I. Roos, A. Antiguedad, A. Aransay, J. Hillert, K. Vandenbroeck (Belfast, UK; Stockholm, S; Bilbao, Derio, E)
Study of protein and gene expression patterns associated with risk haplotypes in the perforin gene in patients with primary progressive multiple sclerosis
   P 678
M. Camiña-Tato, A. Sánchez, E. Julià, C. Tur, M. Tintoré, X. Montalban, M. Comabella (Barcelona, E)
Memetic algorithms as a new method to interpret gene expression profiles in multiple sclerosis
   P 679
M. Cox, N. Bowden, P. Moscato, R. Berretta, R.J. Scott, J.S. Lechner-Scott (Newcastle, New Lambton Heights, AUS)
Homocysteine, plasminogen activator inhibitor-1 (PAI-1), and PAI-1 gene expression in relapsing-remitting multiple sclerosis
   P 680
M.A. Zea-Sevilla, F. Carrillo-Padilla, M.L. Fernández-Sanfiel, P. DeJuan-Hernández (Santa Cruz de Tenerife, E)
Is neuromyelitis optica associated with HLA?
   P 680A
O. Outteryck, I. Fajardy, H. Zéphir, F. Blanc, M. Fleury, P. Vermersch, J. de Sèze (Lille, Strasbourg, F)
OAS in multiple sclerosis: not just a haplotype association
   P 680B
M. O’Brien, L. Costelloe, J. Fletcher, C. Sweeney, K.H.G. Mills, C. O’Farrelly, N. Tubridy (Dublin, IRL)
Selectin gene cluster genetic variation: association study in two independent multiple sclerosis populations
   P 680C
C. Fenoglio, L. Piccio, A.H. Cross, D. Scalabrini, M. Piola, M. De Riz, E. Venturelli, F. Cortini, C. Villa, B. Parks, J. Rinker, N. Bresolin, E. Scarpini, D. Galimberti (Milan, I; St. Louis, USA)